Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Cancer of the Thyroid

1-methyl-3-isobutylxanthine has been researched along with Cancer of the Thyroid in 3 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robinson-White, AJ1
Hsiao, HP1
Leitner, WW1
Greene, E1
Bauer, A1
Krett, NL1
Nesterova, M1
Stratakis, CA1
Mania-Farnell, B1
Davis, TP1
Zink-Lorenz, A1
Komitowska, J1
Raue, F1

Other Studies

3 other studies available for 1-methyl-3-isobutylxanthine and Cancer of the Thyroid

ArticleYear
Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Antineoplast

2008
Modulation of prohormone convertase mRNA by second messenger activators and drugs.
    Annals of the New York Academy of Sciences, 1996, Mar-22, Volume: 780

    Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Sequence; Animals; Blotting, Northern; Cell Line; Cyclic AMP

1996
Norepinephrine induced calcitonin secretion in rat medullary thyroid carcinoma 6-23 cells: interaction between intracellular calcium and cAMP.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1996, Volume: 104, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcitonin; Calcium; Calcium Channel Blockers; Carcinoma, Medu

1996